1.Assessment of Surgical Training for First-Year Postgraduate Trainees; Analysis of Interrater Disagreements.
Yoshiaki SUGIURA ; Yutaka YOSHIZUMI ; Yuichi OZEKI ; Satoshi AIKO ; Tomokazu MATSUYAMA ; Tadashi MAEHARA ; Susumu TANAKA
Medical Education 2002;33(3):157-162
We investigated causes of interrater disagreements in the observational assessment of clinical training for first-year postgraduate trainees. In 1998 25 first-year postgraduates rotated through the Second Department of Surgery for 3 months, including 1 month in cardiovascular surgery, thoracic surgery, and upper-gastrointestinal surgery. Each trainee cared for several patients at most with a senior resident under the supervision of senior staff members. Nine attending physicians (staff members), 3 doctor-course graduates, and 2 chief residents assessed the trainees at the end of the rotation with special reference to clinical, social, and supervisory abilities. Trainees were given scores of “Good, ” “Fair, ” “Pass, ” or “Fail” for each ability. Interrater disagreements often involved responsibility and activeness, which reflected social abilities, and rapid patient consultations, orderly arrangement of laboratory examinations and procedures, and avoiding ordering of unnecessary laboratory examinations and medications, which reflected supervisory abilities. Assessments of poorly performing trainees often disagreed. Some interrater disagreements were seen among 4 of 14 attending physicians, but disagreements were fewer among the 3 doctor-course graduates and 2 chief residents who were graduates of the college. Both the proper training of assessors and a good relationship between assessors and rotators are necessary to make appropriate evaluations that might affect the career of postgraduates trainees.
2.Antioxidant Properties of a Water-soluble Extract from Culture Medium of Ganoderma lucidum (Rei-shi) Mycelia and Antidiabetic Effects in Streptozotocin-treated Mice
Mari OKAZAKI ; Aiko TANAKA ; Yuko HATTA ; Yukiko KAWAHARA ; Shinya KAMIUCHI ; Naohiro IWATA ; Satoshi ASANO ; Fumiko SUZUKI ; Hiroshi IIZUKA ; Yasuhide HIBINO
Japanese Journal of Complementary and Alternative Medicine 2008;5(3):209-218
Objective: Ganoderma lucidum (Rei-shi) is widely used as an alternative medicine agent to promote health and longevity. The water-soluble extract from culture medium of Ganoderma lucidum mycelia (WER) is prepared from a solid medium composed of bagasse and rice bran overgrown for 3–4 months with Ganoderma lucidum mycelia.
Design: In this study, we evaluate antioxidant activity of WER in vitro, and examined the effects of oral treatment of WER on oxidative stress in streptozotocin (STZ)-induced diabetic mice.
Method: Male ICR mice were treated with STZ (150 mg/kg, i.p.) and were housed for a week for induction of experimental diabetic state. WER (1 g/kg daily) was orally administered for an additional 9 weeks, and the levels of blood glucose, oxidative stress in plasma, liver and kidney of the mice were assessed.
Result: WER inhibited generation of superoxide anion and lipid peroxidation in concentration dependent manner in vitro. Oral administration of WER to diabetic mice significantly reduced the levels of blood glucose, hydroperoxides, triglyceride, ALT, and AST. Moreover, WER prevented the increase in lipid peroxide levels and the decrease in activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) in liver and kidney of diabetic mice. In addition, histochemical studies revealed that treatment of WER precluded the sinusoidal dilation in liver and expansion of mesangial matrix in kidney of diabetic mice. Normal mice treated with WER showed no change in any parameters studied.
Conclusion: These data suggested that WER can act as an antioxidant in vivo, and show the antidiabetic effects by relieving diabetic hyperglycemia-induced oxidative stress.
3.Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.
Saori YAMADA ; Ikko KAJIHARA ; Takamitsu JOHNO ; Satoshi FUKUSHIMA ; Masatoshi JINNIN ; Aiko MASUNAGA ; Hirotsugu KOHROGI ; Hironobu IHN
Annals of Dermatology 2016;28(2):269-270
No abstract available.
Arthritis, Psoriatic*
;
Cryptococcosis*
;
Humans
;
Infliximab
4.Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy.
Saori YAMADA ; Ikko KAJIHARA ; Takamitsu JOHNO ; Satoshi FUKUSHIMA ; Masatoshi JINNIN ; Aiko MASUNAGA ; Hirotsugu KOHROGI ; Hironobu IHN
Annals of Dermatology 2016;28(2):269-270
No abstract available.
Arthritis, Psoriatic*
;
Cryptococcosis*
;
Humans
;
Infliximab